Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Controlled Clinical Trial
. 2007 Feb;28(2):309-13.

Imaging degeneration of the substantia nigra in Parkinson disease with inversion-recovery MR imaging

Affiliations
Controlled Clinical Trial

Imaging degeneration of the substantia nigra in Parkinson disease with inversion-recovery MR imaging

L Minati et al. AJNR Am J Neuroradiol. 2007 Feb.

Abstract

Background and purpose: Visualizing with MR imaging and obtaining quantitative indexes of degeneration of the substantia nigra in Parkinson disease have been long-sought goals. We investigated the potential role of area and T1 contrast measurements in differentiating patients from controls and their age-related changes.

Methods: Eight patients with Parkinson disease, 8 age-matched controls, and 8 young controls were imaged. We obtained the pixel-wise difference between 2 sets of inversion-recovery images, acquired parallel to the bicommissural plane, with different inversion times. Pixel-intensity ratios between lateral and medial nigral regions, and nigral area and substantia-nigra/midbrain area ratios were computed.

Results: Compared with that of controls, loss of substantia nigra was evident in patients, its borders taking a smoother and more irregular appearance. Patients were characterized by a lateral-to-medial gradient, due to reduced hypointensity of the lateral portion of the substantia nigra and relative sparing of its medial portion. The visible nigral area was significantly smaller in patients compared with matched controls (P = .04). The substantia nigra/midbrain area ratio enabled considerably better separation (P = .0001). The lateral/medial pixel-intensity ratio was significantly higher in patients compared with matched controls (P = .01) and in young controls compared with age-matched controls (P = .01).

Conclusion: Inversion-recovery sequences may provide a convenient way to visualize nigral degeneration. Relative area and pixel-intensity measurements may integrate other techniques (such as diffusion-tensor imaging on nigrostriatal pathways) in the neuroradiologic diagnosis and follow-up of Parkinson disease by quantitatively assessing the degeneration of the substantia nigra.

PubMed Disclaimer

Figures

Fig 1.
Fig 1.
Positioning of the region of interest (ROI) for area measurement, drawn on the visible substantia nigra (A), and of the ROI for relative contrast measurement, drawn including the whole expected extension of the substantia nigra (B).
Fig 2.
Fig 2.
Appearance of GMS (left column), WMS (middle column), and difference images (GMS-WMS, right column) from an MC (2 upper rows) and a PD (2 lower rows). Reduced hypointensity of the substantia nigra is evident on the difference images from the patient.
Fig 3.
Fig 3.
Distribution of young controls, age-matched controls, and patients on a Cartesian quadrant, having as abscissa, the lateral/medial contrast ratio and as ordinate, the nigral/midbrain area ratio. Separation is not achieved; however, measurements from patients tend to cluster in the area corresponding to reduced nigral area and increased lateral-medial contrast. SN indicates substantia nigra.

References

    1. Elkeslassy A, Miaux Y, Martin-Duverneuil N, et al. MRI of degenerative extrapyramidal syndromes: Parkinson disease, progressive supranuclear palsy and multiple system atrophy. J Neuroradiol. 1996;23:157–63 - PubMed
    1. Ravina B, Eidelberg D, Ahlskog JE, et al. The role of radiotracer imaging in Parkinson disease. Neurology 2005;64:208–15 - PubMed
    1. Ordidge RJ, Gorell JM, Deniau JC, et al. Assessment of relative brain iron concentrations using T2-weighted and T2*-weighted MRI at 3 Tesla. Magn Reson Med 1994;32:335–41 - PubMed
    1. Gorell JM, Ordidge RJ, Brown GG, et al. Increased iron-related MRI contrast in the substantia nigra in Parkinson’s disease. Neurology 1995;45:1138–43 - PubMed
    1. Graham JM, Paley MN, Grunewald RA, et al. Brain iron deposition in Parkinson’s disease imaged using the PRIME magnetic resonance sequence. Brain 2000;123:2423–31 - PubMed

Publication types